Skip to main content

Table 2 Patients diagnosed with neuroblastoma presenting at two collaborating centres over the 29-month study period

From: A comparison of nutritional status in patients with neuroblastoma in Rwanda and United Kingdom: a cross-sectional observational study conducted by the OxPLORE collaboration

 

Rwanda

UK

 

Patients

n = 4

n = 5

Male (%)

2 (50%)

4 (80%)

Age at diagnosisa (months)

57 (6–73)

13 (2–40)

p = 0.09**

Weight in kg a

14 (8–21)

9.8 (5–14)

 

Z score

− 1.57 (− 3.86–0.85)

− 0.7 (1.2 to − 0.91)

p = 0.28**

Height in cma

93.75 (59–117)

86.65 (73.3–100)

 

Z score

− 2.2 (− 2.4–0.72)

1.45 (1.4–1.5)

p = 0.057**

Stage

 I–II

1

3

 III–IV

3

2

Pre-operative chemotherapy

2

3

Surgery

1

3

Post-operative morbidity (Clavien-Dindo)

 I–II

1

2

 III–IV

0

1

Mortality (%)

1 (25%)

0

  1. aMedian (range)
  2. **Unpaired t test